CTRI/2018/11/016367进行中（未招募）未知
Randomized, prospective, three arm, parallel group, double blind clinical study to evaluate the efficacy and safety of fenugreek flakes in two active arms (5g and 10g) on appetite scores vs the control arm
Biogen extracts pvt ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female aged more than or equal to 18 and less than or equal to 65 years of age
- •2.Subjects with BMI more than or equal to 18 to less than or equal to 29.9 kg/m2
- •3.Females of child-bearing age should be willing to use standard methods of contraception
- •4.Must be willing to give written informed consent and comply with the study procedures.
排除标准
- •1. Subjects with diabetes mellitus with HbA1c more than or equal to 7.5
- •2. Subject with any uncontrolled medical condition and/or unstable medical illness
- •3. Subjects with gastrointestinal disorders (e.g., chronic diarrhea, gastro-intestinal diseases, irritable bowel syndrome)
- •4. History of abuse and or addiction to drugs, any substance, cigarette smoking and alcohol.
- •5. Subjects consuming herbal fenugreek products or herbal supplements for the duration of study
研究者
相似试验
招募中
不适用
Comparing endovascular laser, ultrasound-guided foam sclerotherapy, and conventional surgery for the treatment of small saphenous varicose veinsSmall Saphenous vein varicose veinsCirculatory SystemVaricose veins of lower extremitiesISRCTN91735422Åreknudeklinikken (Denmark)330
进行中（未招募）
不适用
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus GlimepirideMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2009-009320-36-DKJanssen Cilag International NV1,281
进行中（未招募）
1 期
A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 100 mg and JNJ-28431754 300 mg Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy The CANTATA-SU Trial (CANagliflozin Treatment And Trial Analysis - Sulfonylurea)MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusType 2 Diabetes MellitusEUCTR2009-009320-36-NOJanssen Cilag International NV
进行中（未招募）
1 期
A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 100 mg and JNJ-28431754 300 mg Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy The CANTATA-SU Trial (CANagliflozin Treatment And Trial Analysis - Sulfonylurea)Type 2 Diabetes MellitusEUCTR2009-009320-36-SKJanssen Cilag International NV1,281
进行中（未招募）
不适用
The CANTATA-SU Trial (Canagliflozin Treatment And Trial Analysis-Sulfonylurea)Type 2 Diabetes MellitusEUCTR2009-009320-36-BGJanssen Cilag International NV1,281